These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 8557348

  • 41. Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion.
    Woehlbier U, Epp C, Hackett F, Blackman MJ, Bujard H.
    Malar J; 2010 Mar 18; 9():77. PubMed ID: 20298576
    [Abstract] [Full Text] [Related]

  • 42. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies.
    Guevara Patiño JA, Holder AA, McBride JS, Blackman MJ.
    J Exp Med; 1997 Nov 17; 186(10):1689-99. PubMed ID: 9362529
    [Abstract] [Full Text] [Related]

  • 43. Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile.
    Collins WE, Pye D, Crewther PE, Vandenberg KL, Galland GG, Sulzer AJ, Kemp DJ, Edwards SJ, Coppel RL, Sullivan JS.
    Am J Trop Med Hyg; 1994 Dec 17; 51(6):711-9. PubMed ID: 7810803
    [Abstract] [Full Text] [Related]

  • 44. Immunogenicity and in vitro protective efficacy of recombinant Mycobacterium bovis bacille Calmette Guerin (rBCG) expressing the 19 kDa merozoite surface protein-1 (MSP-1(19)) antigen of Plasmodium falciparum.
    Nurul AA, Norazmi MN.
    Parasitol Res; 2011 Apr 17; 108(4):887-97. PubMed ID: 21057812
    [Abstract] [Full Text] [Related]

  • 45. Regulation of antibody specificity to Plasmodium falciparum merozoite surface protein-1 by adjuvant and MHC haplotype.
    Chang SP, Nikaido CM, Hashimoto AC, Hashiro CQ, Yokota BT, Hui GS.
    J Immunol; 1994 Apr 01; 152(7):3483-90. PubMed ID: 8144929
    [Abstract] [Full Text] [Related]

  • 46. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.
    Egan AF, Morris J, Barnish G, Allen S, Greenwood BM, Kaslow DC, Holder AA, Riley EM.
    J Infect Dis; 1996 Mar 01; 173(3):765-9. PubMed ID: 8627050
    [Abstract] [Full Text] [Related]

  • 47. Rice-produced MSP142 of Plasmodium falciparum elicits antibodies that inhibit parasite growth in vitro.
    Chen Q, Liang W, Qian F, Qian B, Cao J, Zhang D, Xu Y, Tang L.
    Parasite Immunol; 2016 Oct 01; 38(10):635-41. PubMed ID: 27493141
    [Abstract] [Full Text] [Related]

  • 48. Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.
    Pinder M, Sutherland CJ, Sisay-Joof F, Ismaili J, McCall MB, Ord R, Hallett R, Holder AA, Milligan P.
    Infect Immun; 2006 May 01; 74(5):2887-93. PubMed ID: 16622227
    [Abstract] [Full Text] [Related]

  • 49. Persistence and immunogenicity of chemically attenuated blood stage Plasmodium falciparum in Aotus monkeys.
    De SL, Stanisic DI, van Breda K, Bellete B, Harris I, McCallum F, Edstein MD, Good MF.
    Int J Parasitol; 2016 Aug 01; 46(9):581-91. PubMed ID: 27238088
    [Abstract] [Full Text] [Related]

  • 50. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia.
    Branch OH, Udhayakumar V, Hightower AW, Oloo AJ, Hawley WA, Nahlen BL, Bloland PB, Kaslow DC, Lal AA.
    Am J Trop Med Hyg; 1998 Feb 01; 58(2):211-9. PubMed ID: 9502606
    [Abstract] [Full Text] [Related]

  • 51. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
    Jäschke A, Coulibaly B, Remarque EJ, Bujard H, Epp C.
    Clin Vaccine Immunol; 2017 Nov 01; 24(11):. PubMed ID: 28877929
    [Abstract] [Full Text] [Related]

  • 52. Malaria DNA vaccines in Aotus monkeys.
    Gramzinski RA, Maris DC, Doolan D, Charoenvit Y, Obaldia N, Rossan R, Sedegah M, Wang R, Hobart P, Margalith M, Hoffman S.
    Vaccine; 1997 Jun 01; 15(8):913-5. PubMed ID: 9234546
    [Abstract] [Full Text] [Related]

  • 53. Characterization of a protective Escherichia coli-expressed Plasmodium falciparum merozoite surface protein 3 indicates a non-linear, multi-domain structure.
    Tsai CW, Duggan PF, Jin AJ, Macdonald NJ, Kotova S, Lebowitz J, Hurt DE, Shimp RL, Lambert L, Miller LH, Long CA, Saul A, Narum DL.
    Mol Biochem Parasitol; 2009 Mar 01; 164(1):45-56. PubMed ID: 19073223
    [Abstract] [Full Text] [Related]

  • 54. Prediction of merozoite surface protein 1 and apical membrane antigen 1 vaccine efficacies against Plasmodium chabaudi malaria based on prechallenge antibody responses.
    Lynch MM, Cernetich-Ott A, Weidanz WP, Burns JM.
    Clin Vaccine Immunol; 2009 Mar 01; 16(3):293-302. PubMed ID: 19116303
    [Abstract] [Full Text] [Related]

  • 55. Protection against Plasmodium falciparum challenge induced in Aotus monkeys by liver-stage antigen-3-derived long synthetic peptides.
    Perlaza BL, Valencia AZ, Zapata C, Castellanos A, Sauzet JP, Blanc C, Cohen J, Arévalo-Herrera M, Corradin G, Herrera S, Druilhe P.
    Eur J Immunol; 2008 Sep 01; 38(9):2610-5. PubMed ID: 18792413
    [Abstract] [Full Text] [Related]

  • 56. Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.
    Burns JM, Flaherty PR, Nanavati P, Weidanz WP.
    Infect Immun; 2004 Oct 01; 72(10):5605-12. PubMed ID: 15385457
    [Abstract] [Full Text] [Related]

  • 57. Enhanced protection against malaria by a chimeric merozoite surface protein vaccine.
    Shi Q, Lynch MM, Romero M, Burns JM.
    Infect Immun; 2007 Mar 01; 75(3):1349-58. PubMed ID: 17158895
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.